Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06190197 · ClinicalTrials.gov registry record · Early Phase 1
Prophylactic Antibiotics in Cystectomy With Diversion
A Early Phase 1 study of Muscle-Invasive Bladder Carcinoma and Radical Cystectomy, sponsored by University of Minnesota.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06190197 is a Early Phase 1 study of Muscle-Invasive Bladder Carcinoma and Radical Cystectomy that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 120 participants, roughly in line with the 117-participant average among 14 other Muscle-Invasive Bladder Carcinoma trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT06190197, a Early Phase 1 study of Muscle-Invasive Bladder Carcinoma and Radical Cystectomy, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Using a randomized 2 arm design, this study is being conducted to test for non-inferiority of no prophylactic antibiotic therapy versus the prophylactic oral antibiotic, nitrofurantoin, through comparison of rates of postoperative urinary tract infections within the 90-day postoperative period in patients with muscle invasive bladder cancer who undergo radical cystectomy with urinary diversion.
Conditions Studied
Interventions
- DRUG Prophylactic antibiotics postoperatively.
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-05-13 |
| Est. Completion | 2027-10-15 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06190197
The ClinicalTrials.gov registry entry for NCT06190197 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 117-participant average among 14 other Muscle-Invasive Bladder Carcinoma trials with a reported enrollment target. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Muscle-Invasive Bladder Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Prophylactic antibiotics postoperatively. is the first listed.
NCT06190197 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06190197 about?
NCT06190197 is a clinical study titled "Prophylactic Antibiotics in Cystectomy With Diversion". Using a randomized 2 arm design, this study is being conducted to test for non-inferiority of no prophylactic antibiotic therapy versus the prophylactic oral antibiotic, nitrofurantoin, through comparison of rates of postoperative urinary tract infections within the 90-day postoperative period in pa...
What is the current status of trial NCT06190197?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 120 participants. The study started on 2024-05-13. Estimated completion is 2027-10-15.
What conditions does trial NCT06190197 study?
This clinical trial studies the following conditions: Muscle-Invasive Bladder Carcinoma, Radical Cystectomy, Ileal Conduit, Neobladder Diversion.
What interventions are being tested in trial NCT06190197?
The interventions under investigation include: Prophylactic antibiotics postoperatively. (DRUG).
Who is sponsoring clinical trial NCT06190197?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06190197 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Muscle-Invasive Bladder Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
RECRUITING · Phase 1
-
Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)
RECRUITING · Phase 2
-
Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology
RECRUITING · Phase 2
-
Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
RECRUITING · NA
-
Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer
RECRUITING · Phase 1
-
Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.